報價延遲最少15分鐘:2025/06/28 13:06 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
18.9 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.25/-1.40
|
|
企業價值
718.07M
|
| 資產負債 |
|
每股賬面淨值
5.00
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
45.23M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/28 13:06 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. |